Trials with Rmc-4630
Every colorectal cancer trial that includes this drug. Those looking for patients come first.
Showing 1–2 of 2
NCT04185883
To evaluate the safety and tolerability of sotorasib administered in investigational regimens in adult participants with KRAS p.G12C mutant advanced solid tumors.
NCT04916236
This is a Phase I/Ib study in which the safety of the combination therapy of RMC-4630 and LY3214996 in the treatment of KRAS mutant cancers will be studied.